Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| IPHA (Innate Pharma S.A.) | -2.29% | -20.47% | -16.71% | -14.62% | NA | NA | NA | … | … |
Data as of 06/05/2026, Common starting date is 10/18/2019
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| IPHA (Innate Pharma S.A.) | 10/18/2019 | 06/05/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -6.56 | -20.47 | -16.71 | -14.62 | NA | NA | NA | … | … | -2.29 | -4.89 | -24.64 | -24.93 | -18.20 | 11.49 | -36.49 | 4.89 |
| Sharpe Ratio | NA | -0.28 | -0.23 | -0.20 | NA | NA | NA | … | … | -0.07 | -0.12 | -0.30 | -0.44 | -0.23 | 0.15 | -0.39 | 0.55 |
| Standard Deviation(%) | NA | 81.90 | 86.76 | 84.34 | NA | NA | NA | … | … | 104.02 | 65.76 | 103.32 | 67.01 | 83.74 | 75.38 | 95.08 | 47.45 |
| Draw Down(%) | NA | 50.84 | 66.57 | 85.56 | NA | NA | NA | … | … | 36.07 | 32.81 | 52.00 | 43.78 | 60.42 | 46.42 | 54.02 | 12.06 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/05/2026, Common starting date is 10/18/2019
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| IPHA (Innate Pharma S.A.) |
-32.29%
Nov 2021 – Nov 2024 |
-24.52%
Nov 2019 – Nov 2024 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| IPHA (Innate Pharma S.A.) |
-1.18%
Sep 2022 – Sep 2025 |
-12.85%
Sep 2020 – Sep 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart